Akero Therapeutics, Inc. Operating Lease Liability
Akero Therapeutics, Inc. had Operating Lease Liability of $605.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-07
- 2025-09-30: Operating Lease, Liability $605.00K.
- 2025-06-30: Operating Lease, Liability $679.00K.
- 2025-03-31: Operating Lease, Liability $750.00K.
- 2024-12-31: Operating Lease, Liability $820.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-09-30 | $605.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $679.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $750.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $820.00K 10-K · filed 2025-02-28 |
| 2024-09-30 | $888.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $954.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.08M 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.20M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.25M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.31M 10-K · filed 2023-03-17 |
| 2022-09-30 | $1.36M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $1.42M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $1.47M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $1.52M 10-K · filed 2022-02-25 |
| 2021-09-30 | $1.56M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.61M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.66M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.70M 10-K · filed 2021-03-16 |
| 2020-09-30 | $1.74M 10-Q · filed 2020-11-12 |
| 2020-03-31 | $230.00K 10-Q · filed 2020-05-13 |